Pharmaceuticals benzodiazepines

Dietary compounds are represented in a number of highly successful drugs such as lovastatin 31 and salicylic acid, the archetypal statin and non-steroid anti-inflammatory drugs, respectively. Lovastatin occurs in the red yeast of rice Monascus ruber),91 an ingredient of Eastern cuisine used to give a red colour to the Pekinese duck, while salicylic acid is ubiquitous in plants.92 Other important dietary drug candidates are curcumin 32 from turmeric and capsaicin from hot pepper 33,93 while traces of pharmaceutical benzodiazepines (including diazepam) occur in common edible plants such as potatoes and cherries.5... 

A number of controlled cUnical trials have been performed to evaluate the efficacy of the benzodiazepine receptor antagonist flumazenil in HE patients. In a subset of these patients, improvements following flumazenil have been spectacular. However, enthusiasm for this approach has been tempered by the possible confounding effects of prior exposure of patients to pharmaceutical benzodiazepines (used as sedatives or as part of an endoscopic work-up in cirrhotic patients) and by the poor correlation between the clinical response and blood levels of benzodiazepines in these patients. Adding to these difficulties is the short half-life and lack of an oral formulation for flumazenil. 

Authors are designed row sensitive and selective test-systems for analysis of heavy metals, active chlorine, phenols, nitrates, nitrites, phosphate etc. for analysis of objects of an environment and for control of ions Ee contents in the technological solutions of KH PO, as well as for testing some of pharmacological psychotropic daigs alkaloids (including opiates), cannabis as well as pharmaceutical preparations of phenothiazines, barbiturates and 1,4-benzodiazepines series too. 

Benzodiazepine partial inverse agonist MEM 1003 Memory Pharmaceuticals... 

Zopiclone is a chiral cyclopyrrolone with hypnotic properties, possessing a pharmaceutical profile of high efficacy and low toxicity, similar to that of benzodiazepines. Zopiclone has been commercialized as a racemic mixture however, the (S)-enantiomer is more active and less toxic than the (R)-enantiomer [11]. Although enzymatic hydrolysis of esters or transesteriflcation processes of alcohols have been widely applied for enzymatic resolution or desymmetrization... 

Indeed, as early as 1981 a study carried out into trace organic substances in the river Lee [3] identified a number of pharmaceutical derived species including metabolites of the benzodiazepines, phenobarbitone, ethinyl estradiol, and clofi-bric and salicylic acids. They recognized that pharmaceuticals can enter the aquatic environment through two main channels-from manufacturing processes and through patient use-and that the latter route was the most important and the more difficult to control. 

The 1,4-benzodiazepine class of pharmaceuticals (see Fig. 26.6), which are in widespread clinical use today, all possess intrinsic electrochemical activity that renders them ideal for voltammetric studies. Senkowski et al. were the first to perform a comprehensive study of this class of compounds by polarography [77] and demonstrated that the 1,4-benzodiazepines show a wave for the two-electron reduction of the 4,5-azomethine electrophore in a supporting electrolyte of 0.1 M HCI containing 20% methanol. Secondary polarographic waves... 

While there are no newly reported naturally occurring benzodiazepines since the first survey (7 ). the interest in this area remains high. The current status of research and clinical implications has been reviewed (1484). It is noted that natural benzodiazepines, including seven known halogenated examples (1), are found in soil, plants, animal and human tissues, and are chemically identical to their pharmaceutical counterparts. The endogenous formation of benzodiazepines by plant cells (Artemisia dracunculus and Solarium tuberosum) has been demonstrated for delor-azepam, temazepam, and diazepam (1485). 

More than 220 producers of CRMs throughout the world produce today 12,000 20,000 materials with dif ferent matrixes, analytes and properties [4]. However, many testing (analytical) laboratories cannot find suitable CRMs in the market and develop in-house reference materials (IHRMs) themselves. Often IHRMs are developed in a laboratory to conserve the corresponding expensive CRMs. For example, a pharmaceutical company Chemagis Ltd. produces 30 active pharmaceutical ingredients steroids, benzodiazepines, antihistamines, hipolipidaemics, blood flow reactants, etc. Only for a few of them Mo-metasone Furoate, Fluticasone Propionate and Dobutamine Hydrochloride are of fi-cial reference standards for assay supplied by US, British and European Pharmacopoeias with prices of about 180 per unit (50 200 mg). Thus, to support its customers Chemagis is forced to develop IHRMs for assay as well as for impurities and related substances of each produced compound. Therefore, certification of such IHRMs that leads to traceable values is very important. 

---